About usSign in

BGV (BioGeneration Ventures)

Status
ACTIVE
Global HQ
Naarden, Netherlands
Countries of investment
  • United Kingdom
  • Ireland
Investment stages
  • Pre-Seed
  • Seed
Industries
  • Consumer Health
  • Pharmaceuticals
  • Biotech
  • Health & Hospital Services
  • Digital Health
About
BioGeneration Ventures (BGV) is a venture capital firm specializing in earlystage life sciences investments. They leverage extensive sector expertise and a robust network to support the growth of innovative biotech companies across Europe.
Min check size
$25K
Max check size
$2M
Fund size
NPS

Investment Thesis

BioGeneration Ventures focuses on earlystage life sciences companies, investing in biopharma, biotechnology, drug discovery, and development. They aim to transform innovative research into successful commercial ventures, emphasizing sustainability and significant societal impact.
Lead investor
Co Invest
Number of exits
Preferred contact method

Team

Investment Team:

Edward van Wezel – Managing Partner

Oskar Slotboom – Managing Partner

Daniela Couto

PhD – General Partner

Keno Gutierrez

PhD – General Partner

Diede Brunen

PhD – Principal

Venture Partners:

Rob de Ree – Venture Partner

Arnoud Dijkstra

PhD – Venture Partner

Wouter Verhoeven – Venture Partner

Alexander Vos – Venture Partner

Elena Ritsou

PhD – Venture Partner

Advisors:

Arnon Kater – Senior Advisor

Emile Voest – Senior Advisor

Roger Ulrich – Senior Advisor

John J.P. Kastelein

MD PhD FESC – Senior Advisor

Jeff Sharman

MD – Senior Advisor

Operations:

Robbert van de Griendt – Head of Investment Relations

Cyril Lesser – Senior Controller

Laura Asbjornsen

LLM

MBA – Head of Communications

Machteld Groeneveld

LLM

EMBA – Legal Counsel & Compliance Officer

Patricia Vonk – AML/KYC Manager

Administration and Support:

Dragana Dragusin – Executive Assistant

Olga Ziessen – Manager Secretarial Services

Portfolio

Artica Therapeutics

Azafaros

Brenig

Catalym

Citryll

Complement Therapeutics

Confo Therapeutics

Dualyx

Dunad

Fibrocor

FundaMental Pharma

Genase Therapeutics

Mironid

NorthSea Therapeutics

Phlox

Phosphoenix

RhyGaze

Scenic Biotech

Tessellate Bio

Tiga Tx

VarmX

VectorY

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp